500.01 Safety and Performance of the Resorbable Magnesium Scaffold, Magmaris in a Real-World Setting - 12-Month Follow-Up of First 600 Subjects in Biosolve-IV Registry

Abstract

The aim of this registry is to investigate the clinical performance and long-term safety of the Resorbable Magnesium Scaffold (Magmaris; BIOTRONIK AG, Buelach, Switzerland) in a real-world setting. Up to 2054 subjects in up to 120 clinical sites in Europe, Asia, and Asia-Pacific countries will be